Current Challenges in Covid-19 Testing
From the beginning, diagnostic testing has been critical to monitoring and treating patients and controlling the spread of covid-19. Here’s a look at where we are now, and what comes next.
Read More
Search Results for: point-of-care
Advancing the Diagnosis of Vaginitis
Two FDA-approved molecular testing platforms are leading to better targeted treatments for this common infection.
Read More
Study Demonstrates New Tool for Rapid Evaluation of Acute Leukemia Patients
PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.
Read More
FDA EUA for Genalyte’s Rapid Covid-19 Antibody Test
The panel tests for IgG and IgM antibodies and delivers lab-quality results in 20 minutes at point-of-care.
Read More
FDA EUA for Quidel’s Rapid Antigen “ABC Test” for Influenza A and B and Covid-19
The Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.
Read More